Reverb Therapeutics

📍 Vancouver, Canada🗓 Founded 2023👥 14 employees💰 Last funded Dec 2024
Biotechnology Research🌐 reverbtx.com
Website LinkedIn
We develop bispecific antibodies that exploit the potential of the natural immune system. Our Amplify•R platform amplifies and redirects endogenous cytokine signaling instead of recombinant cytokines. We avoid issues such as systemic toxicity, immunogenicity and manufacturing concerns.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
1
Frequently asked questions
Who invested in Reverb Therapeutics?
Reverb Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Reverb Therapeutics last raise funding?
The most recent investment in Reverb Therapeutics recorded on gritt.io was in December 2024.
When was Reverb Therapeutics founded?
Reverb Therapeutics was founded in 2023.
What industry is Reverb Therapeutics in?
Reverb Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Reverb Therapeutics based?
Reverb Therapeutics is headquartered in Vancouver, Canada.